Share Facebook Twitter LinkedIn Pinterest Telegram Email System1 rating upgraded by S&P on debt restructuring Source link
AstraZeneca holds talks with Bristol Myers Squibb on $400 billion megadeal, FT reports By ReutersAugust 2, 2026